IPO filing research

BioStem Technologies, Inc.

Biological Products, (No Diagnostic Substances) · BSEM

follow-on amended OTC DRS/A

BioStem Technologies, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: DRS/A on 2026-05-28. Current deal snapshot: exchange OTC.

Filing Timeline

SEC EDGAR

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior RW filing.

2026-05-28 · 0001213900-26-061738

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

First tracked pre-IPO filing for this issuer.

BioStem Technologies, Inc. filed a DRS form disclosing audited financial statements for 2025 and 2024, with KPMG LLP as auditors. The company faces material uncertainties about its ability to continue as a going concern due to net accumulated deficits, expected losses, and contractual obligations from the BioTissue acquisition and an existing loan. Revenue is heavily concentrated (99% in 2025) with a single distributor under a distribution agreement. The audit opinion is unqualified, but the going concern assumption is noted as uncertain.

2026-04-20 · 0001213900-26-045321

RW withdrawn

Withdrawal request

Issuer requested withdrawal of the registration statement.

First tracked pre-IPO filing for this issuer.

BioStem Technologies, Inc. has submitted an application to withdraw its previously filed Registration Statement on Form 10, initially filed on September 27, 2024. The company cites the need to revise the registration statement and financial statements to address comments from the SEC. No securities were sold in connection with the original filing.

2025-10-28 · 0001193125-25-253609

Comparable Deals

17 comparable deals

Healthcare & BiotechLast 18 months

Only 0 strict matches; expanded to 17 using nearest neighbors.

Showing top 8 by similarity.

-8.2%

Median day-1

47%

Above issue

-2.1%

Median week-1

-20.9%

Downside (p10)

SL Science Holding Ltd SLBT

2026-06-15 - Day 1: -16.8% Wk 1: +13.0%

same SICrecent IPO

Odyssey Therapeutics, Inc. ODTX

2026-05-08 $279M Day 1: -8.8% Wk 1: -3.8%

same SICrecent IPO

Hemab Therapeutics Holdings, Inc. COAG

2026-05-01 $302M Day 1: +88.9% Wk 1: +43.0%

same SICrecent IPO

Standard Nuclear, Inc. STDN

2026-07-16 $150M Day 1: -8.2% Wk 1: -8.2%

same SIC grouprecent IPO

Kardigan, Inc. KARD

2026-06-18 $400M Day 1: +37.5% Wk 1: +41.1%

same SIC grouprecent IPO

Agomab Therapeutics NV AGMB

2026-02-06 $200M Day 1: -8.4% Wk 1: -2.1%

same SICrecent IPO

Eikon Therapeutics, Inc. EIKN

2026-02-05 $381M Day 1: -16.7% Wk 1: -19.5%

same SICrecent IPO

Parabilis Medicines, Inc. PBLS

2026-06-10 $670M Day 1: +58.0% Wk 1: +30.2%

same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.